Pamela Esposito
Director/Board Member bij KYMERA THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Pamela Esposito is an Independent Director at Kymera Therapeutics, Inc. She is also a Director at Accent Therapeutics, Inc. and an Advisor at Atlas Venture Advisors, Inc. Previously, she worked as a Director at BioDuro (Beijing) Co., Ltd.
and as the Head of Business Development & Commercialization at Vion Pharmaceuticals, Inc. She also served as a Principal at Galenea Corp.
and BioDuro LLC.
Additionally, she held the position of Vice President of Business Development at BioVex Group, Inc. and Chief Business Officer at Ra Pharmaceuticals, Inc. She was also the Head of Corporate Development at Angiochem, Inc. Currently, she is the Chief Business Officer at Replimune Group, Inc. Dr. Esposito completed her undergraduate studies at Dartmouth College and earned a doctorate degree from Tufts University School of Medicine in 2002.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
REPLIMUNE GROUP, INC.
0.43% | 12-09-2023 | 263 436 ( 0.43% ) | 2 M $ | 31-03-2024 |
15-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Pamela Esposito
Bedrijven | Functie | Begin |
---|---|---|
KYMERA THERAPEUTICS, INC. | Director/Board Member | 04-09-2020 |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Director/Board Member | - |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
Eerdere bekende functies van Pamela Esposito
Bedrijven | Functie | Einde |
---|---|---|
REPLIMUNE GROUP, INC. | Investor Relations Contact | - |
RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2015 |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | 30-09-2013 |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Corporate Officer/Principal | 31-12-2011 |
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Director/Board Member | 31-12-2009 |
Opleiding van Pamela Esposito
Dartmouth College | Undergraduate Degree |
Tufts University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
REPLIMUNE GROUP, INC. | Health Technology |
KYMERA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 9 |
---|---|
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Galenea Corp.
Galenea Corp. Pharmaceuticals: MajorHealth Technology Galenea Corp. is an emerging biotechnology company which engaged in the discovery of novel therapies for central nervous system (CNC) and respiratory diseases. The firm is focusing initially on utilizing proprietary technologies to generate calcineurin-related treatments for schizophrenia. It also offers synaptic transmission drug discovery platform for alzheimer’s disease (AD), parkinson’s disease, huntington’s disease, epilepsy, bipolar depression, schizophrenia, autism spectrum disorders, and traumatic brain injury. The company was founded Jianzhu chen, Susumu Tonegawa, Maria Karayiorgou, and David J. Gerber in 2004 and is headquartered in Wakefield, MA. | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
BioDuro LLC
BioDuro LLC Miscellaneous Commercial ServicesCommercial Services BioDuro LLC provides research and development services for the life science industry. It offers services in the areas of chemistry, discovery biology, drug metabolism and pharmacokinetics and pharmacology, as well as integrated preclinical research and development. The company was founded by Masood K. Tayebi and John V. Oyler in 2005 and is headquartered in San Diego, CA. | Commercial Services |
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Health Technology |
BioDuro (Beijing) Co., Ltd.
BioDuro (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services BioDuro (Beijing) Co., Ltd. operates as a integrated drug discovery outsourcing company that provides integrated research and development services to biopharmaceutical clients. Its services range from medicinal chemistry to discovery biology, pharmacology, drug metabolism and pharmacokinetics (DMPK) and drug safety evaluation. The company was founded in 2006 and is headquartered in Beijing, China. | Commercial Services |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Health Technology |